◆英語タイトル：Scar Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
	◆商品コード：MOR23AP069 ◆発行会社（リサーチ会社）：Mordor Intelligence ◆発行日：2023年1月23日 ◆ページ数：114 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン ◆産業分野：医療

Scar Treatment Market is believed to witness a CAGR of 9% over the forecast period (2022-2027).

The COVID-19 pandemic had a significant impact on the scar treatment market. During the pandemic, the e-commerce industry boomed drastically and people started relying more on online purchases of aesthetic products. This helped the e-commerce end users of the scar treatment market to keep a good pace in the pandemic. However, hospitals and retail drug stores faced a huge decline in the overall sale of products concerned with scar treatment. In addition, due to the lockdown in major countries, traveling declined during the year 2020-2021 which resulted in the declined number of road accidents and scars associated with the same. Therefore, it is observed that the scar treatment market has seen a significant decline in its value during the COVID-19 pandemic. However, with the pandemic in control and all healthcare services restarted, it is expected that the market will gain its pace rapidly in the short term.

Moreover, The market is majorly driven by the factors such as increasing road accidents and growing concerns of the general population about aesthetic appearance. As stated by the World Health Organization 2020 report, every year, the lives of more than 1.35 million people are cut short as a result of a road traffic crash. Between 20 and 50 million more people suffer non-fatal injuries, with many incurring a disability as a result of their injury. There have been continuous advancements in scar treatment technology. For instance, dermabrasion, CO2 laser, micro-needling, and microplasma technology are expected to witness wide adoption owing to their efficacy in scar treatment. Lately, the use of silicone sheets and steroid injections are also getting attention in scar treatment. Hence, such emerging technologies are expected to propel market growth in the future.

Major companies in the global market provide unique products that are approved by the United States Food and Drug Administration. For instance, Sientra, Inc. provides BIOCORNEUM which is the only advanced scar treatment with FDA-Cleared Silishield patented cross-linked medical grade silicone and SPF 30. With the presence of such advanced products, scar treatment has become easier. As a result, the market is growing.

Other driving factors for the market studied include technological advancements in skincare and growing concerns regarding aesthetic appearance, especially in developed markets. However, the high cost of laser-based products acts as a major barrier to the scar treatment market.

Scar Treatment Market Trends

Atrophic Scars to Witness Rapid Growth Over the Forecast Period

When the skin is unable to repair tissue, atrophic scars develop. As a result, it causes uneven scarring. Atrophic scars are primarily characterized by the sunken area often visible as pitted skin. Several factors may be responsible for creating atrophic scars in the skin, such as exposure to inflammatory conditions for a long period, accident, surgery, or other genetic factors. One of the corrective measures initially applied are gentle cleansing agents, moisturizers, and soaps, which are not harsh and irritant on the skin, but remove bacteria, dirt, and oil from the skin. The ice-pack scars represent 60-70% of atrophic scars, as stated by the report from AWD Supplies which is one of the well-known companies providing scar treatment solutions.

New techniques such as triple steps acne scar revision are proving to be effective in treating atrophic scars. In addition, there is a growing trend of aesthetic procedures across developing and developed countries, as suggested by the ISAPS (International Society for Aesthetic Plastic Surgery) data 2021.

When compared to other skin conditions, the atrophic scars are relatively common, wherein about 80% of the adolescent population are affected by it, to some degree, as per the National Institute of Health. The awareness level regarding this scar type is rather high, globally. Since atrophic scars are more common, the treatment for the same is being taken largely which is ultimately increasing the market size.

North America is the largest market for Scar Treatment

North America witnesses a significantly high number of road accidents. In such accidents, several die, and several are bruised for a long term, where scars occur as part of the healing process, naturally. According to the estimates of the Insurance Institute for Highway Safety (IIHS) and Highway Loss Data Institute (HLDI), in 2020 there were 35,165 motor vehicle crashes in the United States, in which around 38,824 deaths occurred.

A 2021 report from ISAPS stated that the United States is a country with the most non-surgical aesthetic procedures which accounted for around 3,182,815 as of 2020. This high number of aesthetic procedures also includes the treatments taken for scars which are boosting the market growth in the United States.

In North America, insurance is covered for several scar treatment products. The submission of a product as per the insurance codes listed for different types of scars and treatment options varies. However, in the case of laser treatment, since the therapy is considered a cosmetic procedure, most insurance companies do not cover the cost of the treatment. There are several procedures under cosmetic dermatology practices, such as soft tissue augmentation fillers, skin needling, and punch excision, which are popular in scar treatment.

Scar Treatment Market Competitor Analysis

The market is fragmented because of the presence of major market players and these players are focusing on research and development, market expansions, partnerships, mergers in order to experience stable growth. Some of the market players are Alliance Pharma., Bausch Health, Smith & Nephew plc, Merz, Inc., Lumenis, Sonoma Pharmaceuticals, Inc., Mölnlycke Health Care, Cynosure, Inc., Suneva Medical, Inc. and Sientra, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support